In this context, App knock-in mice, which possess less artifacts and may in many aspects more accurately recapitulate Aβ-related pathological processes in AD compared with first-generation APP-overexpressing transgenic mice, could provide a valuable translational tool. This evidence concerns the gene APP and Alzheimer disease.